NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 83 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $43,651 | +351.9% | 52,591 | +281.1% | 0.00% | – |
| Q1 2023 | $9,660 | -93.7% | 13,800 | -90.7% | 0.00% | – |
| Q2 2022 | $153,000 | -13.6% | 148,402 | +58.5% | 0.00% | – |
| Q1 2022 | $177,000 | -67.0% | 93,640 | -15.8% | 0.00% | – |
| Q4 2021 | $536,000 | +232.9% | 111,174 | +397.1% | 0.00% | – |
| Q3 2021 | $161,000 | -91.1% | 22,366 | -88.5% | 0.00% | – |
| Q2 2021 | $1,802,000 | -26.7% | 195,262 | -2.2% | 0.00% | – |
| Q1 2021 | $2,458,000 | -10.6% | 199,631 | +2.5% | 0.00% | – |
| Q4 2020 | $2,748,000 | -37.2% | 194,856 | -46.6% | 0.00% | -100.0% |
| Q3 2020 | $4,377,000 | +280.3% | 364,759 | +426.1% | 0.00% | – |
| Q2 2020 | $1,151,000 | -7.5% | 69,333 | -36.6% | 0.00% | – |
| Q1 2020 | $1,244,000 | – | 109,317 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,156,200 | $10,672,000 | 1.77% |
| ACT CAPITAL MANAGEMENT, LLC | 239,000 | $2,207,000 | 1.13% |
| EcoR1 Capital, LLC | 2,358,804 | $21,772,000 | 0.81% |
| Redmile Group, LLC | 3,919,235 | $36,175,000 | 0.54% |
| Boxer Capital, LLC | 1,501,058 | $13,855,000 | 0.49% |
| Baker Brothers Advisors | 3,821,740 | $35,275,000 | 0.16% |
| Sio Capital Management, LLC | 38,312 | $354,000 | 0.09% |
| Highland Private Wealth Management | 46,999 | $434,000 | 0.06% |
| PERSONAL CFO SOLUTIONS, LLC | 23,710 | $219,000 | 0.04% |
| Point72 Asset Management, L.P. | 883,102 | $8,151,000 | 0.04% |